Advertisement

ADVERTISEMENT

Jolynn Tumolo

FDA Approves First Biosimilar for Relapsing Forms of MS
News
FDA Approves First Biosimilar for Relapsing Forms of MS
09/14/2023
Jolynn Tumolo
The US Food and Drug Administration (FDA) recently approved Tyruko (natalizumab-sztn), the first biosimilar of Tysabri (natalizumab) injection, for the treatment of adults with relapsing forms of multiple sclerosis (MS).
The US Food and Drug Administration (FDA) recently approved Tyruko (natalizumab-sztn), the first biosimilar of Tysabri (natalizumab) injection, for the treatment of adults with relapsing forms of multiple sclerosis (MS).
The US Food and Drug...
09/14/2023
Neurology
stock paperwork
News
Written Exposure Therapy on Par With Prolonged Exposure Therapy for PTSD
09/12/2023
Jolynn Tumolo
Written exposure therapy (WET) was non-inferior to more time-intensive prolonged exposure therapy (PE) in veterans with PTSD, according to findings published in JAMA Psychiatry.
Written exposure therapy (WET) was non-inferior to more time-intensive prolonged exposure therapy (PE) in veterans with PTSD, according to findings published in JAMA Psychiatry.
Written exposure therapy (WET)...
09/12/2023
Psych Congress Network
News
Persistence, Switching in Patients With PsA Similar With Ixekizumab and Secukinumab
09/12/2023
Jolynn Tumolo
Researchers found that real-world treatment patterns and use of adjunctive pain and anti-inflammatory medications may be similar in patients with PsA initiating ixekizumab and secukinumab. 
Researchers found that real-world treatment patterns and use of adjunctive pain and anti-inflammatory medications may be similar in patients with PsA initiating ixekizumab and secukinumab. 
Researchers found that...
09/12/2023
First Report Managed Care
At-Home Sleep EEG Oscillations May Signal Preclinical Alzheimer Disease
News
At-Home Sleep EEG Oscillations May Signal Preclinical Alzheimer Disease
09/11/2023
Jolynn Tumolo
Changes in at-home sleep electroencephalography (EEG) may serve as an early biomarker of neurodegeneration associated with Alzheimer disease (AD), suggests a study published in Alzheimer’s & Dementia. 
Changes in at-home sleep electroencephalography (EEG) may serve as an early biomarker of neurodegeneration associated with Alzheimer disease (AD), suggests a study published in Alzheimer’s & Dementia. 
Changes in at-home sleep...
09/11/2023
Neurology
News
Ongoing Study of IL-23 in Asthma May Yield More Treatment Options
09/11/2023
Jolynn Tumolo
A new study suggests that gaining a better understanding of the relationship between interleukin (IL)-23 and airway inflammation in asthma patients could lead to alternative treatment options beyond traditional anti-type 2 inflammatory...
A new study suggests that gaining a better understanding of the relationship between interleukin (IL)-23 and airway inflammation in asthma patients could lead to alternative treatment options beyond traditional anti-type 2 inflammatory...
A new study suggests that...
09/11/2023
First Report Managed Care
Four Gastrointestinal Syndromes May Specifically Predict Parkinson Disease
News
Four Gastrointestinal Syndromes May Specifically Predict Parkinson Disease
09/10/2023
Jolynn Tumolo
Dysphagia, gastroparesis, constipation, and IBS without diarrhea appear to increase the risk of a subsequent diagnosis of idiopathic Parkinson disease, according to a study published online ahead of print in the journal Gut.
Dysphagia, gastroparesis, constipation, and IBS without diarrhea appear to increase the risk of a subsequent diagnosis of idiopathic Parkinson disease, according to a study published online ahead of print in the journal Gut.
Dysphagia, gastroparesis,...
09/10/2023
Neurology
digital brain
News
Digital Therapeutic Eases Experiential Negative Symptoms in Patients with Schizophrenia
09/09/2023
Jolynn Tumolo
A beta version of a prescription digital therapeutic significantly reduced experiential negative symptoms in patients with schizophrenia, according to a poster presentation at Psych Congress.
A beta version of a prescription digital therapeutic significantly reduced experiential negative symptoms in patients with schizophrenia, according to a poster presentation at Psych Congress.
A beta version of a prescription...
09/09/2023
Psych Congress Network
News
Viloxazine ER Added to Stimulant Treatment for Pediatric ADHD Appears Safe, Effective
09/09/2023
Jolynn Tumolo
Extended-release viloxazine administered with stimulant medication improved symptoms of ADHD in pediatric patients with an initial inadequate response to stimulant medication, according to a poster presentation at Psych Congress. 
Extended-release viloxazine administered with stimulant medication improved symptoms of ADHD in pediatric patients with an initial inadequate response to stimulant medication, according to a poster presentation at Psych Congress. 
Extended-release viloxazine...
09/09/2023
Psych Congress Network
News
Anticonvulsant Recalled
09/08/2023
Jolynn Tumolo
A recall due to cross contamination has been issued for cartons of vigabatrin distributed throughout the United States.
A recall due to cross contamination has been issued for cartons of vigabatrin distributed throughout the United States.
A recall due to cross...
09/08/2023
Pharmacy Learning Network
News
Acne Medication Recalled
09/08/2023
Jolynn Tumolo
A recall for more than 11,000 bottles of clindamycin phosphate topical solution because of a container defect causing leakage.
A recall for more than 11,000 bottles of clindamycin phosphate topical solution because of a container defect causing leakage.
A recall for more than 11,000...
09/08/2023
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
November 1 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use